City Holding Co’s Teva Pharmaceutical Industries Limited TEVA Stock Holding History

City Holding Co’s Portfolio TEVA Stock Details TEVA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q2	–	Sell	-500	Closed	-$9K	–	565
2018 Q1	$9K	Hold	500	–	–	﹤0.01%	404
2017 Q4	$9K	Hold	500	–	–	﹤0.01%	413
2017 Q3	$9K	Hold	500	–	–	﹤0.01%	405
2017 Q2	$17K	Hold	500	–	–	0.01%	363
2017 Q1	$16K	Hold	500	–	–	0.01%	368
2016 Q4	$18K	Hold	500	–	–	0.01%	334
2016 Q3	$23K	Hold	500	–	–	0.01%	309
2016 Q2	$25K	Hold	500	–	–	0.01%	305
2016 Q1	$27K	Hold	500	–	–	0.01%	280
2015 Q4	$33K	Hold	500	–	–	0.02%	258
2015 Q3	$28K	Hold	500	–	–	0.02%	267
2015 Q2	$30K	Hold	500	–	–	0.02%	268
2015 Q1	$31K	Hold	500	–	–	0.02%	272
2014 Q4	$29K	Hold	500	–	–	0.02%	270
2014 Q3	$27K	Hold	500	–	–	0.02%	260
2014 Q2	$27K	Hold	500	–	–	0.02%	263
2014 Q1	$26K	Hold	500	–	–	0.02%	246
2013 Q4	$20K	Buy	+500	New	+$19.7K	0.01%	266

Other funds holding TEVA

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

Berkshire Hathaway Omaha, Nebraska $299B AUM 27.55% 1-Year Est. Return

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

HCM

Highfields Capital Management Boston, Massachusetts $68.3M AUM 21.64% 1-Year Est. Return

Northern Cross Boston, Massachusetts $279M AUM 1.98% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

ACM

Abrams Capital Management Boston, Massachusetts $5.48B AUM 3.63% 1-Year Est. Return

City Holding Co's TEVA Position: Q2 2018 in Review

City Holding Co sold out of Teva Pharmaceutical Industries Limited (TEVA) in Q2 2018, closing a stake of 500 shares — an estimated $9K sold.

City Holding Co first reported a position in TEVA in Q4 2013 and held it in 18 quarters. The position peaked at $33K in Q4 2015. 539 funds tracked by Wall St. Rank hold TEVA as of Q2 2018.

City Holding Co reported no remaining Teva Pharmaceutical Industries Limited position as of Q2 2018 after selling out during the quarter.
City Holding Co sold 500 Teva Pharmaceutical Industries Limited shares in Q2 2018, an estimated $9K.
City Holding Co first reported a position in Teva Pharmaceutical Industries Limited in Q4 2013 and held it in 18 quarters.
City Holding Co's Teva Pharmaceutical Industries Limited position peaked at $33K in Q4 2015.
539 funds tracked by Wall St. Rank held Teva Pharmaceutical Industries Limited as of Q2 2018.

Based on City Holding Co's 13F filing for Q2 2018, filed 20 Aug 2018.